CNY 10.24
(-0.1%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 1.14 Billion CNY | 10.51% |
2022 | 933.11 Million CNY | 14.93% |
2021 | 827.66 Million CNY | 21.72% |
2020 | 679.95 Million CNY | 0.62% |
2019 | 716.7 Million CNY | 25.96% |
2018 | 536.47 Million CNY | 15.0% |
2017 | 461.04 Million CNY | 9.86% |
2016 | 416.15 Million CNY | 14.18% |
2015 | 368.36 Million CNY | 7.82% |
2014 | 340.73 Million CNY | -6.05% |
2013 | 318.32 Million CNY | 11.78% |
2012 | 325.65 Million CNY | -46.85% |
2011 | 617.97 Million CNY | 240.86% |
2010 | 180.33 Million CNY | 35.61% |
2009 | 133.1 Million CNY | 28.06% |
2008 | 104.06 Million CNY | 32.27% |
2007 | 77.92 Million CNY | 39.66% |
2006 | 57.37 Million CNY | 16.54% |
2005 | 48.68 Million CNY | 31.02% |
2004 | 37.01 Million CNY | 3.71% |
2003 | 35.89 Million CNY | 19.78% |
2002 | 29.04 Million CNY | -21.06% |
2001 | 37.74 Million CNY | 159.15% |
2000 | -39.65 Million CNY | -100.93% |
1999 | -35.57 Million CNY | -175.79% |
1998 | -15.95 Million CNY | -162.03% |
1997 | 18.2 Million CNY | 52.41% |
1996 | 12.17 Million CNY | 40.74% |
1995 | 8.65 Million CNY | -62.16% |
1994 | 22.87 Million CNY | -1.07% |
1993 | 23.11 Million CNY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q3 | 191.61 Million CNY | -29.53% |
2024 Q2 | 309.69 Million CNY | 25.73% |
2024 Q1 | 225.86 Million CNY | -4.61% |
2023 Q3 | 197.04 Million CNY | -19.93% |
2023 Q4 | 221.73 Million CNY | 12.53% |
2023 FY | - CNY | 10.51% |
2023 Q1 | 222.59 Million CNY | 27.66% |
2023 Q2 | 246.09 Million CNY | 10.56% |
2022 Q2 | 246.26 Million CNY | 23.73% |
2022 Q4 | 174.36 Million CNY | -5.88% |
2022 FY | - CNY | 14.93% |
2022 Q3 | 185.25 Million CNY | -24.77% |
2022 Q1 | 199.02 Million CNY | 38.37% |
2021 Q3 | 170.72 Million CNY | -16.2% |
2021 Q2 | 203.71 Million CNY | 17.02% |
2021 Q1 | 174.09 Million CNY | 54.36% |
2021 Q4 | 143.83 Million CNY | -15.75% |
2021 FY | - CNY | 21.72% |
2020 Q1 | 150.19 Million CNY | 13.43% |
2020 FY | - CNY | 0.62% |
2020 Q4 | 112.78 Million CNY | -33.98% |
2020 Q3 | 170.83 Million CNY | 0.25% |
2020 Q2 | 170.4 Million CNY | 13.46% |
2019 Q3 | 136.51 Million CNY | -23.8% |
2019 Q2 | 179.14 Million CNY | 20.21% |
2019 Q4 | 132.41 Million CNY | -3.0% |
2019 FY | - CNY | 25.96% |
2019 Q1 | 149.03 Million CNY | 45.8% |
2018 Q2 | 120.89 Million CNY | -4.44% |
2018 Q1 | 126.51 Million CNY | 20.51% |
2018 Q4 | 102.21 Million CNY | -20.68% |
2018 FY | - CNY | 15.0% |
2018 Q3 | 128.86 Million CNY | 6.59% |
2017 FY | - CNY | 9.86% |
2017 Q2 | 104.97 Million CNY | 1.21% |
2017 Q1 | 103.72 Million CNY | 1.61% |
2017 Q3 | 100.53 Million CNY | -4.24% |
2017 Q4 | 104.98 Million CNY | 4.43% |
2016 FY | - CNY | 14.18% |
2016 Q1 | 98.07 Million CNY | 39.62% |
2016 Q2 | 84.12 Million CNY | -14.23% |
2016 Q3 | 93.42 Million CNY | 11.07% |
2016 Q4 | 102.08 Million CNY | 9.26% |
2015 Q1 | 94.52 Million CNY | 46.74% |
2015 FY | - CNY | 7.82% |
2015 Q3 | 92.98 Million CNY | 28.22% |
2015 Q4 | 70.24 Million CNY | -24.45% |
2015 Q2 | 72.51 Million CNY | -23.28% |
2014 Q2 | 83.63 Million CNY | 10.11% |
2014 Q4 | 64.41 Million CNY | -24.89% |
2014 FY | - CNY | -6.05% |
2014 Q1 | 75.95 Million CNY | -22.49% |
2014 Q3 | 85.77 Million CNY | 2.55% |
2013 Q1 | 69.33 Million CNY | -15.38% |
2013 Q4 | 97.99 Million CNY | 28.54% |
2013 Q3 | 76.23 Million CNY | -43.11% |
2013 FY | - CNY | 11.78% |
2013 Q2 | 134 Million CNY | 93.29% |
2012 FY | - CNY | -46.85% |
2012 Q1 | 66.31 Million CNY | -84.93% |
2012 Q2 | 72.35 Million CNY | 9.1% |
2012 Q3 | 82.65 Million CNY | 14.24% |
2012 Q4 | 81.93 Million CNY | -0.88% |
2011 FY | - CNY | 240.86% |
2011 Q1 | 53.72 Million CNY | 11.15% |
2011 Q4 | 440 Million CNY | 705.79% |
2011 Q2 | 447.15 Million CNY | 732.25% |
2011 Q3 | 54.6 Million CNY | -87.79% |
2010 Q3 | 41.1 Million CNY | -12.33% |
2010 Q2 | 46.89 Million CNY | 40.64% |
2010 Q1 | 33.34 Million CNY | -6.75% |
2010 FY | - CNY | 35.61% |
2010 Q4 | 48.33 Million CNY | 17.58% |
2009 Q3 | 28.99 Million CNY | -18.77% |
2009 FY | - CNY | 28.06% |
2009 Q4 | 35.75 Million CNY | 23.33% |
2009 Q2 | 35.69 Million CNY | 50.71% |
2009 Q1 | 23.68 Million CNY | 0.96% |
2008 Q4 | 23.45 Million CNY | -8.38% |
2008 Q3 | 25.6 Million CNY | -8.95% |
2008 Q2 | 28.12 Million CNY | 51.44% |
2008 Q1 | 18.56 Million CNY | -49.98% |
2008 FY | - CNY | 32.27% |
2007 Q2 | 17.06 Million CNY | 111.57% |
2007 Q4 | 37.12 Million CNY | 165.97% |
2007 FY | - CNY | 39.66% |
2007 Q1 | 8.06 Million CNY | -65.03% |
2007 Q3 | 13.95 Million CNY | -18.21% |
2006 Q2 | 14.32 Million CNY | 26.15% |
2006 Q1 | 11.35 Million CNY | -43.1% |
2006 FY | - CNY | 16.54% |
2006 Q4 | 23.07 Million CNY | 117.63% |
2006 Q3 | 10.6 Million CNY | -26.02% |
2005 Q4 | 19.96 Million CNY | 129.49% |
2005 Q1 | 10.84 Million CNY | -27.13% |
2005 Q3 | 8.69 Million CNY | -24.84% |
2005 FY | - CNY | 31.02% |
2005 Q2 | 11.57 Million CNY | 6.67% |
2004 Q2 | 9.47 Million CNY | 24.61% |
2004 Q4 | 14.88 Million CNY | 117.77% |
2004 FY | - CNY | 3.71% |
2004 Q1 | 7.6 Million CNY | -69.69% |
2004 Q3 | 6.83 Million CNY | -27.82% |
2003 Q4 | 25.08 Million CNY | 625.35% |
2003 FY | - CNY | 19.78% |
2003 Q1 | 1.7 Million CNY | -81.68% |
2003 Q2 | 15.07 Million CNY | 786.26% |
2003 Q3 | 3.45 Million CNY | -77.06% |
2002 Q1 | 6.12 Million CNY | -86.6% |
2002 FY | - CNY | -21.06% |
2002 Q4 | 9.28 Million CNY | 633.93% |
2002 Q3 | 1.26 Million CNY | -78.82% |
2002 Q2 | 5.97 Million CNY | -2.47% |
2001 Q1 | -6.19 Million CNY | 0.0% |
2001 FY | - CNY | 159.15% |
2001 Q3 | -9.52 Million CNY | -83.81% |
2001 Q4 | 45.67 Million CNY | 579.57% |
2001 Q2 | -5.18 Million CNY | 16.34% |
2000 FY | - CNY | -100.93% |
1999 FY | - CNY | -175.79% |
1998 FY | - CNY | -162.03% |
1997 FY | - CNY | 52.41% |
1996 FY | - CNY | 40.74% |
1995 FY | - CNY | -62.16% |
1994 FY | - CNY | -1.07% |
1993 FY | - CNY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Zhejiang Zhenyuan Share Co., Ltd. | 220.46 Million CNY | -417.832% |
Hunan Jingfeng Pharmaceutical Co.,Ltd. | -83.34 Million CNY | 1469.793% |
Hubei Guangji Pharmaceutical Co., Ltd. | -2.67 Million CNY | 42829.726% |
Yifan Pharmaceutical Co., Ltd. | -483.52 Million CNY | 336.104% |
Guangdong Jiaying Pharmaceutical Co., Ltd | 66.15 Million CNY | -1625.791% |
Sichuan Kelun Pharmaceutical Co., Ltd. | 4.85 Billion CNY | 76.499% |
Chongqing Lummy Pharmaceutical Co., Ltd. | 116.49 Million CNY | -879.982% |
Boai NKY Medical Holdings Ltd. | 665.28 Million CNY | -71.598% |
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | 391.09 Million CNY | -191.905% |